Prevalence of Diabetic Retinopathy in Various Ethnic Groups: A Worldwide Perspective

Survey of Ophthalmology

Volumn 57, Issue 4, 2012, Pages 347-370

  Sivaprasad, Sobha ^a,b   Gupta, Bhaskar ^a   Crosby Nwaobi, Roxanne ^b   Evans, Jennifer ^c  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Diabetes; Diabetic retinopathy; Global; Incidence; Prevalence; Risk factors

Indexed keywords

AFRICA; AFRICAN AMERICAN; AMERICAN INDIAN; ARTICLE; ASIAN AMERICAN; AUSTRALIA; CANADA; CHINA; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DISEASE SURVEILLANCE; EPIDEMIOLOGICAL DATA; ETHNIC DIFFERENCE; ETHNICITY; EUROPE; HISPANIC; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPOGLYCEMIA; INDIAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MIDDLE EAST; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RISK; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

DIABETIC RETINOPATHY; ETHNIC GROUPS; HUMANS; INCIDENCE; PREVALENCE; RISK FACTORS; WORLD HEALTH;

EID: 84862619470     PISSN: 00396257     EISSN: 18793304     Source Type: Journal    
DOI: 10.1016/j.survophthal.2012.01.004     Document Type: Article

References (290)

1. Agardh C.D., Agardh E., Torffvit O. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type I diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care. Diabetes Res Clin Pract 1997, 35:113-121.
2. Agarwal S., Raman R., Kumari R.P., et al. Diabetic retinopathy in type II diabetics detected by targeted screening versus newly diagnosed in general practice. Ann Acad Med Singapore 2006, 35:531-535.
3. Al-Maskari F., El-Sadig M. Prevalence of diabetic retinopathy in the United Arab Emirates: a cross-sectional survey. BMC Ophthalmol 2007, 7:11.
4. Alwakeel J.S., Sulimani R., Al-Asaad H., et al. Diabetes complications in 1952 type 2 diabetes mellitus patients managed in a single institution in Saudi Arabia. Ann Saudi Med 2008, 28:260-266.
5. Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus. American Academy of Pediatrics. Sections on Endocrinology and Ophthalmology. Pediatrics 1998, 101:313-314. American Academy of Pediatrics.
6. Amini M., Parvaresh E. Prevalence of macro- and microvascular complications among patients with type 2 diabetes in Iran: a systematic review. Diabetes Res Clin Pract 2009, 83:18-25.
7. Appiah A.P., Ganthier R., Watkins N. Delayed diagnosis of diabetic retinopathy in black and Hispanic patients with diabetes mellitus. Ann Ophthalmol 1991, 23:156-158.
8. Arar N.H., Freedman B.I., Adler S.G., et al. Heritability of the severity of diabetic retinopathy: the FIND-Eye study. Invest Ophthalmol Vis Sci 2008, 49:3839-3845.
9. Arfken C.L., Salicrup A.E., Meuer S.M., et al. Retinopathy in African Americans and whites with insulin-dependent diabetes mellitus. Arch Intern Med 1994, 154:2597-2602.
10. Bachmann M.O., Eachus J., Hopper C.D., et al. Socio-economic inequalities in diabetes complications, control, attitudes and health service use: a cross-sectional study. Diabet Med 2003, 20:921-929.
11. Backlund L.B., Algvere P.V., Rosenqvist U. New blindness in diabetes reduced by more than one-third in Stockholm County. Diabet Med 1997, 14:732-740.
12. Baker R.S., Watkins N.L., Wilson M.R., et al. Demographic and clinical characteristics of patients with diabetes presenting to an urban public hospital ophthalmology clinic. Ophthalmology 1998, 105:1373-1379.
13. Balarajan R. Trends in mortality from diabetes in England and Wales among those born in the Indian subcontinent and the Caribbean Commonwealth. Ethn Health 1998, 3:55-58.
14. Bamashmus M.A., Gunaid A.A., Khandekar R.B. Diabetic retinopathy, visual impairment and ocular status among patients with diabetes mellitus in Yemen: A hospital-based study. Indian J Ophthalmol 2009, 57:293-298.
15. Barrett J.C., Clayton D.G., Concannon P., et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009, 41:703-707.
16. Berinstein D.M., Stahn R.M., Welty T.K., et al. The prevalence of diabetic retinopathy and associated risk factors among Sioux Indians. Diabetes Care 1997, 20:757-759.
17. Beulens J.W., Kruidhof J.S., Grobbee D.E., et al. Alcohol consumption and risk of microvascular complications in type 1 diabetes patients: the EURODIAB Prospective Complications Study. Diabetologia 2008, 51:1631-1638.
18. Beynat J., Charles A., Astruc K., et al. Screening for diabetic retinopathy in a rural French population with a mobile non-mydriatic camera. Diabetes Metab 2009, 35:49-56.
19. Bojestig M., Arnqvist H.J., Karlberg B.E., et al. Unchanged incidence of severe retinopathy in a population of type I diabetic patients with marked reduction of nephropathy. Diabet Med 1998, 15:863-869.
20. Bonney M., Hing S.J., Fung A.T., et al. Development and progression of diabetic retinopathy: adolescents at risk. Diabet Med 1995, 12:967-973.
21. Borchers A.T., Uibo R., Gershwin M.E. The geoepidemiology of type 1 diabetes. Autoimmun Rev 2010, 9:A355-A365.
22. Brazionis L., Rowley K., Itsiopoulos C., et al. Is risk of diabetic retinopathy lower in Australia's Greek-born migrants?. Diabet Med 2010, 27:660-665.
23. Brian G., Fischer-Harder K., Sikivou B., et al. Diabetic eye disease among adults in Fiji with self-reported diabetes. Clin Experiment Ophthalmol 2010, 38:867-874.
24. Brooks B., Chong R., Ho I., et al. Diabetic retinopathy and nephropathy in Fiji: comparison with data from an Australian diabetes centre. Aust NZ J Ophthalmol 1999, 27:9-13.
25. Brown J.B., Pedula K.L., Summers K.H. Diabetic retinopathy: contemporary prevalence in a well-controlled population. Diabetes Care 2003, 26:2637-2642.
26. Burger W., Hovener G., Dusterhus R., et al. Prevalence and development of retinopathy in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. A longitudinal study. Diabetologia 1986, 29:17-22.
27. Cahill M., Halley A., Codd M., et al. Prevalence of diabetic retinopathy in patients with diabetes mellitus diagnosed after the age of 70 years. Br J Ophthalmol 1997, 81:218-222.
28. Carter J.S., Gilliland S.S., Perez G.E., et al. Public health and clinical implications of high hemoglobin A1c levels and weight in younger adult Native American people with diabetes. Arch Intern Med 2000, 160:3471-3476.
29. Carter P.J., Cutfield W.S., Hofman P.L., et al. Ethnicity and social deprivation independently influence metabolic control in children with type 1 diabetes. Diabetologia 2008, 51:1835-1842.
30. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2005 2010, Centers for Disease Control and Prevention (CDC), US Department of Health and Human Services, Atlanta, GA.
31. Chang C., Lu F., Yang Y.C., et al. Epidemiologic study of type 2 diabetes in Taiwan. Diabetes Res Clin Pract 2000, 50(Suppl 2):S49-S59.
32. Chang C.J., Fu C.C., Chen M.S., et al. A comparison of newly and previously diagnosed diabetics in Taiwan. J Form Med Assoc 1990, 89:264-269.
33. Chaturvedi N., Jarrett J., Morrish N., et al. Differences in mortality and morbidity in African Caribbean and European people with non-insulin dependent diabetes mellitus: results of 20-year follow-up of a London cohort of a multinational study. BMJ 1996, 313:848-852.
34. Chaturvedi N., Porta M., Klein R., et al. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. Lancet 2008, 372:1394-1402.
35. Chaturvedi N., Sjolie A.K., Stephenson J.M., et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 1998, 351:28-31.
36. Chen M.S., Kao C.S., Chang C.J., et al. Prevalence and risk factors of diabetic retinopathy among noninsulin-dependent diabetic subjects. Am J Ophthalmol 1992, 114:723-730.
37. Chen M.S., Kao C.S., Fu C.C., et al. Incidence and progression of diabetic retinopathy among non-insulin-dependent diabetic subjects: a 4-year follow-up. Int J Epidemiol 1995, 24:787-795.
38. Chetthakul T., Deerochanawong C., Suwanwalaikorn S., et al. Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 2 diabetes mellitus. J Med Assoc Thai 2006, 89(Suppl 1):S27-S36.
39. Chetthakul T., Likitmaskul S., Plengvidhya N., et al. Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 1 diabetes mellitus. J Med Assoc Thai 2006, 89(Suppl 1):S17-S26.
40. Chiang F., Kuper H., Lindfield R., et al. Rapid assessment of avoidable blindness in the Occupied Palestinian Territories. PLoS One 2010, 5:e11854.
41. Chin M.H., Zhang J.X., Merrell K. Diabetes in the African American Medicare population. Morbidity, quality of care, and resource utilization. Diabetes Care 1998, 21:1090-1095.
42. Collins V.R., Dowse G.K., Plehwe W.E., et al. High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa. Diabetes Care 1995, 18:1140-1149.
43. Congdon N.G., Friedman D.S., Lietman T. Important causes of visual impairment in the world today. JAMA 2003, 290:2057-2060.
44. Connolly V., Unwin N., Sherriff P., et al. Diabetes prevalence and socioeconomic status: a population based study showing increased prevalence of type 2 diabetes mellitus in deprived areas. J Epidemiol Community Health 2000, 54:173-177.
45. Conway B.N., Miller R.G., Orchard T.J. Are hemoglobin levels elevated in type 1 diabetes?. Diabetes Care 2010, 33:341-343.
46. Cruickshank J.K., Alleyne S.A. Black West Indian and matched white diabetics in Britain compared with diabetics in Jamaica: body mass, blood pressure, and vascular disease. Diabetes Care 1987, 10:170-179.
47. Cugati S., Cikamatana L., Wang J.J., et al. Five-year incidence and progression of vascular retinopathy in persons without diabetes: the Blue Mountains Eye Study. Eye 2006, 20:1239-1245.
48. Dandona L., Dandona R., Naduvilath T.J., et al. Population based assessment of diabetic retinopathy in an urban population in southern India. Br J Ophthalmol 1999, 83:937-940.
49. Danielsen R., Jonasson F., Helgason T. Prevalence of retinopathy and proteinuria in type 1 diabetics in Iceland. Acta Med Scand 1982, 212:277-280.
50. Danne T., Weber B., Hartmann R., et al. Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Follow-up of the Berlin Retinopathy Study. Diabetes Care 1994, 17:1390-1396.
51. Das B.N., Thompson J.R., Patel R., et al. The prevalence of eye disease in Leicester: a comparison of adults of Asian and European descent. J R Soc Med 1994, 87:219-222.
52. De Block C.E., De Leeuw I.H., Van Gaal L.F. Impact of overweight on chronic microvascular complications in type 1 diabetic patients. Diabetes Care 2005, 28:1649-1655.
53. Dedov I., Maslova O., Suntsov Y., et al. Prevalence of diabetic retinopathy and cataract in adult patients with type 1 and type 2 diabetes in Russia. Rev Diabet Stud 2009, 6:124-129.
54. Delcourt C., Vauzelle-Kervroedan F., Cathelineau G., et al. Low prevalence of long-term complications in non-insulin-dependent diabetes mellitus in France: a multicenter study. CODIAB-INSERM-ZENECA Pharma Study Group. J Diabetes Complicat 1998, 12:88-95.
55. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med 2006, 23:857-866. DIAMOND study group.
56. Donaghue K.C., Fairchild J.M., Craig M.E., et al. Do all prepubertal years of diabetes duration contribute equally to diabetes complications?. Diabetes Care 2003, 26:1224-1229.
57. Dowse G.K., Humphrey A.R., Collins V.R., et al. Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol 1998, 147:448-457.
58. Ebeling P., Koivisto V.A. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland. Acta Diabetol 1997, 34:33-38.
59. el Haddad O.A., Saad M.K. Prevalence and risk factors for diabetic retinopathy among Omani diabetics. Br J Ophthalmol 1998, 82:901-906.
60. El-Asrar A.M., Al-Rubeaan K.A., Al-Amro S.A., Kangave D., Moharram O.A. Risk factors for diabetic retinopathy among Saudi diabetics. Int Ophthalmol 1998, 22:155-161.
61. Elbagir M.N., Eltom M.A., Mahadi E.O., et al. Pattern of long-term complications in Sudanese insulin-treated diabetic patients. Diabetes Res Clin Pract 1995, 30:59-67.
62. Elshafei M., Gamra H., Khandekar R., et al. Prevalence and determinants of diabetic retinopathy among persons 40 years of age with diabetes in Qatar: a community-based survey. Eur J Ophthalmol 2010, 21:39-47.
63. Emanuele N., Moritz T., Klein R., et al. Ethnicity, race, and clinically significant macular edema in the Veterans Affairs Diabetes Trial (VADT). Diabetes Res Clin Pract 2009, 86:104-110.
64. Emanuele N., Sacks J., Klein R., et al. Ethnicity, race, and baseline retinopathy correlates in the veterans affairs diabetes trial. Diabetes Care 2005, 28:1954-1958.
65. Erasmus R.T., Alanamu R.A., Bojuwoye B., et al. Diabetic retinopathy in Nigerians: relation to duration of diabetes, type of treatment and degree of control. East Afr Med J 1989, 66:248-254.
66. Esteves J.F., Kramer C.K., Azevedo M.J., et al. Prevalence of diabetic retinopathy in patients with type 1 diabetes mellitus. Rev Assoc Med Bras 2009, 55:268-273.
67. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 1994, 37:278-285. EURODIAB.
68. Fairchild J.M., Hing S.J., Donaghue K.C., et al. Prevalence and risk factors for retinopathy in adolescents with type 1 diabetes. Med J Aust 1994, 160:757-762.
69. Falck A.A., Kaar M.L., Laatikainen L.T. Prevalence and risk factors of retinopathy in children with diabetes. A population-based study on Finnish children. Acta Ophthalmol (Copenh) 1993, 71:801-809.
70. Farrell M.A., Quiggins P.A., Eller J.D., et al. Prevalence of diabetes and its complications in the Eastern Band of Cherokee Indians. Diabetes Care 1993, 16:253-256.
71. Flack A., Kaar M.L., Laatikainen L. A prospective, longitudinal study examining the development of retinopathy in children with diabetes. Acta Paediatr 1996, 85:313-319.
72. Fong D.S., Aiello L.P., Ferris F.L., et al. Diabetic retinopathy. Diabetes Care 2004, 27:2540-2553.
73. Foster A., Resnikoff S. The impact of Vision 2020 on global blindness. Eye (Lond) 2005, 19:1133-1135.
74. Frederikson L.G., Jacobs R.J. Diabetes eye screening in the Wellington region of New Zealand: characteristics of the enrolled population (2002-2005). NZ Med J 2008, 121:21-34.
75. Gill G.V., Mbanya J.C., Ramaiya K.L., Tesfaye S. A sub-Saharan African perspective of diabetes. Diabetologia 2009, 52:8-16.
76. Giuffre G., Lodato G., Dardanoni G. Prevalence and risk factors of diabetic retinopathy in adult and elderly subjects: The Casteldaccia Eye Study. Graefes Arch Clin Exp Ophthalmol 2004, 242:535-540.
77. Golbahar J., Rahimi M., Tabei M.B., et al. Clinical risk factors and association of hyperhomocysteinemia with diabetic retinopathy in Iranian type 2 diabetes patients. A cross-sectional study from Shiraz, Southern Iran. Diabetes Metab Syndr 2008, 2:192-201.
78. Gomes M.B., Dorigo D., da Silva Junior G.R., et al. Prospective study of development of microalbuminuria and retinopathy in Brazilian IDDM patients. Acta Diabetol 2000, 37:19-25.
79. Gul K., Ustun I., Aydin Y., et al. Carotid intima-media thickness and its relations with the complications in patients with type 1 diabetes mellitus. Anadolu Kardiyol Derg 2010, 10:52-58.
80. Haffner S.M., Hazuda H.P., Stern M.P., et al. Effects of socioeconomic status on hyperglycemia and retinopathy levels in Mexican Americans with NIDDM. Diabetes Care 1989, 12:128-134.
81. Hallman D.M., Huber J.C., Gonzalez V.H., et al. Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. Diabetes Care 2005, 28:1163-1168.
82. Hamman R.F., Mayer E.J., Moo-Young G.A., et al. Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM. San Luis Valley Diabetes Study. Diabetes 1989, 38:1231-1237.
83. Harjo T.C., Perez A., Lopez V., et al. Prevalence of diabetes and cardiovascular risk factors among California Native American adults compared to other ethnicities: The 2005 California Health Interview Survey. Metab Syndr Relat Disord 2011, 9:49-54.
84. Harris E.L., Feldman S., Robinson C.R., et al. Racial differences in the relationship between blood pressure and risk of retinopathy among individuals with NIDDM. Diabetes Care 1993, 16:748-754.
85. Harris E.L., Sherman S.H., Georgopoulos A. Black-white differences in risk of developing retinopathy among individuals with type 2 diabetes. Diabetes Care 1999, 22:779-783.
86. Harris M.I., Klein R., Cowie C.C., et al. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A US population study. Diabetes Care 1998, 21:1230-1235.
87. Herman W.H., Aubert R.E., Engelgau M.M., et al. Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications. Diabet Med 1998, 15:1045-1051.
88. Herman W.H., Dungan K.M., Wolffenbuttel B.H., et al. Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. J Clin Endocrinol Metab 2009, 94:1689-1694.
89. Hietala K., Harjutsalo V., Forsblom C., et al. Age at onset and the risk of proliferative retinopathy in type 1 diabetes. Diabetes Care 2010, 33:1315-1319.
90. Hirvela H., Laatikainen L. Diabetic retinopathy in people aged 70 years or older. The Oulu Eye Study. Br J Ophthalmol 1997, 81:214-217.
91. Hove M.N., Kristensen J.K., Lauritzen T., et al. The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Arhus County, Denmark. Acta Ophthalmol Scand 2004, 82:443-448.
92. Hovind P., Tarnow L., Rossing K., et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 2003, 26:1258-1264.
93. Hu Y.H., Pan X.R., Liu P.A., et al. Coronary heart disease and diabetic retinopathy in newly diagnosed diabetes in Da Qing, China: the Da Qing IGT and Diabetes Study. Acta Diabetol 1991, 28:169-173.
94. Ikegami H., Noso S., Babaya N., et al. Genetic basis of type 1 diabetes: similarities and differences between east and west. Rev Diabet Stud 2008, 5:64-72.
95. IDF Diabetic Atlas 2009, International Diabetes Federation, IDF, Montreal. 4th edition.
96. Jamal-u-Din, Qureshi M.B., Khan A.J., et al. Prevalence of diabetic retinopathy among individuals screened positive for diabetes in five community-based eye camps in northern Karachi, Pakistan. J Ayub Med Coll Abbottabad 2006, 18:40-43.
97. Jandeleit-Dahm K., Cooper M.E. Hypertension and diabetes: role of the renin-angiotensin system. Endocrinol Metab Clin North Am 2006, 35:469-490. vii.
98. Jaross N., Ryan P., Newland H. Prevalence of diabetic retinopathy in an Aboriginal Australian population: results from the Katherine Region Diabetic Retinopathy Study (KRDRS). Report no. 1. Clin Experiment Ophthalmol 2003, 31:32-39.
99. Javadi M.A., Katibeh M., Rafati N., et al. Prevalence of diabetic retinopathy in Tehran province: a population-based study. BMC Ophthalmol 2009, 9:12.
100. Johansen J., Sjolie A.K., Elbol P., et al. The relation between retinopathy and albumin excretion rate in insulin-dependent diabetes mellitus. From the Funen County Epidemiology of Type 1 Diabetes Complications Survey. Acta Ophthalmol (Copenh) 1994, 72:347-351.
101. Jonas J.B., Xu L., Wang Y.X. The Beijing Eye Study. Acta Ophthalmol 2009, 87:247-261.
102. Joner G., Brinchmann-Hansen O., Torres C.G., Hanssen K.F. A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type 1 (insulin-dependent) diabetic patients. Diabetologia 1992, 35:1049-1054.
103. Kahn H.A., Milton R.C. Revised Framingham Eye Study (mdash) prevalence of glaucoma and diabetic retinopathy. Am J Epidemiol 1980, 111:769-776.
104. Kalk W.J., Joannou J., Ntsepo S., et al. Ethnic differences in the clinical and laboratory associations with retinopathy in adult onset diabetes: studies in patients of African, European and Indian origins. J Intern Med 1997, 241:31-37.
105. Kalm H., Egertsen R., Blohme G. Non-stereo fundus photography as a screening procedure for diabetic retinopathy among patients with type II diabetes. Compared with 60D enhanced slit-lamp examination. Acta Ophthalmol (Copenh) 1989, 67:546-553.
106. Kalter-Leibovici O., Leibovici L., Loya N., et al. The development and progression of diabetic retinopathy in type I diabetic patients: a cohort study. Diabet Med 1997, 14:858-866.
107. Kempen J.H., O'Colmain B.J., Leske M.C., et al. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 2004, 122:552-563.
108. Kernell A., Dedorsson I., Johansson B., et al. Prevalence of diabetic retinopathy in children and adolescents with IDDM. A population-based multicentre study. Diabetologia 1997, 40:307-310.
109. Khan A.R., Wiseberg J.A., Lateef Z.A., et al. Prevalence and determinants of diabetic retinopathy in Al hasa region of Saudi Arabia: primary health care centre based cross-sectional survey, 2007-2009. Middle East Afr J Ophthalmol 2010, 17:257-263.
110. Khandekar R., Mohammed A.J. Gender inequality in vision loss and eye diseases: evidence from the Sultanate of Oman. Indian J Ophthalmol 2009, 57:443-449.
111. Kim H.K., Kim C.H., Kim S.W., et al. Development and progression of diabetic retinopathy in Koreans with NIDDM. Diabetes Care 1998, 21:134-138.
112. Klein R., Davis M.D., Moss S.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. A comparison of retinopathy in younger and older onset diabetic persons. Adv Exp Med Biol 1985, 189:321-335.
113. Klein R., Klein B.E. Are individuals with diabetes seeing better? A long-term epidemiological perspective. Diabetes 2010, 59:1853-1860.
114. Klein R., Klein B.E., Moss S.E. A population-based study of diabetic retinopathy in insulin-using patients diagnosed before 30 years of age. Diabetes Care 1985, 1(Suppl 8):71-76.
115. Klein R., Klein B.E., Moss S.E. The Wisconsin epidemiologic study of diabetic retinopathy: an update. Aust NZ J Ophthalmol 1990, 18:19-22.
116. Klein R., Klein B.E., Moss S.E., et al. The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994, 112:1217-1228.
117. Klein R., Klein B.E., Moss S.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995, 102:7-16.
118. Klein R., Klein B.E., Moss S.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy IV. Diabetic macular edema. Ophthalmology 1984, 91:1464-1474.
119. Klein R., Klein B.E., Moss S.E., et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984, 102:520-526.
120. Klein R., Klein B.E., Moss S.E., et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984, 102:527-532.
121. Klein R., Klein B.E., Moss S.E., et al. Retinopathy in young-onset diabetic patients. Diabetes Care 1985, 8:311-315.
122. Klein R., Klein B.E., Moss S.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1989, 107:237-243.
123. Klein R., Klein B.E., Moss S.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol 1989, 107:244-249.
124. Klein R., Klein B.E., Moss S.E., et al. The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology 1992, 99:58-62.
125. Klein R., Klein B.E., Moss S.E., et al. The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol 2004, 122:76-83.
126. Klein R., Klein B.E.K., Moss S.E., et al. The Wisconsin Epidemiological Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type I diabetes. Ophthalmology 1998, 105:1801-1815.
127. Klein R., Knudtson M.D., Lee K.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 2008, 115:1859-1868.
128. Klein R., Knudtson M.D., Lee K.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology 2009, 116:497-503.
129. Klein R., Marino E.K., Kuller L.H., et al. The relation of atherosclerotic cardiovascular disease to retinopathy in people with diabetes in the Cardiovascular Health Study. Br J Ophthalmol 2002, 86:84-90.
130. Klein R., Moss S.E., Klein B.E., et al. The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology 1989, 96:1501-1510.
131. Klein R., Sharrett A.R., Klein B.E., et al. The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes: the atherosclerosis risk in communities study. Ophthalmology 2002, 109:1225-1234.
132. Knudsen L.L., Lervang H.H., Lundbye-Christensen S., et al. The North Jutland County Diabetic Retinopathy Study: population characteristics. Br J Ophthalmol 2006, 90:1404-1409.
133. Ko G.T., Chan J.C., Lau M., et al. Diabetic microangiopathic complications in young Chinese diabetic patients: a clinic-based cross-sectional study. J Diabetes Complicat 1999, 13:300-306.
134. Kohner E.M., Aldington S.J., Stratton I.M., et al. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998, 116:297-303.
135. Kokkonen J., Laatikainen L., van D.K., et al. Ocular complications in young adults with insulin-dependent diabetes mellitus since childhood. Acta Paediatr 1994, 83:273-278.
136. Kola L.D., Sumaili E.K., Krzesinski J.M. How to treat hypertension in blacks: review of the evidence. Acta Clin Belg 2009, 64:466-476.
137. Kristinsson J.K., Stefansson E., Jonasson F., et al. Screening for eye disease in type 2 diabetes mellitus. Acta Ophthalmol (Copenh) 1994, 72:341-346.
138. Kristinsson J.K., Stefansson E., Jonasson F., et al. Systematic screening for diabetic eye disease in insulin dependent diabetes. Acta Ophthalmol (Copenh) 1994, 72:72-78.
139. Kuiv R., Tein P., Algvere P.V., et al. Photographic detection of retinopathy in insulin-treated diabetes. A population study in the city of Tartu, Estonia. Acta Ophthalmol Scand 1997, 75:447-456.
140. Lanting L.C., Bootsma A.H., Lamberts S.W., et al. Ethnic differences in internal medicine referrals and diagnosis in the Netherlands. BMC Public Health 2008, 8:287.
141. Larsson L.I., Alm A., Bergenheim T., et al. Retinopathy in diabetic patients aged 15-50 years in the county of Umea, Sweden. Acta Ophthalmol Scand 1999, 77:430-436.
142. Lee E.T., Lee V.S., Kingsley R.M., et al. Diabetic retinopathy in Oklahoma Indians with NIDDM. Incidence and risk factors. Diabetes Care 1992, 15:1620-1627.
143. Lee E.T., Lu M., Bennett P.H., et al. Vascular disease in younger-onset diabetes: comparison of European, Asian and American Indian cohorts of the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001, 44(Suppl 2):S78-S81.
144. Leese G.P., Ahmed S., Newton R.W., et al. Use of mobile screening unit for diabetic retinopathy in rural and urban areas. BMJ 1993, 306:187-189.
145. Leske M.C., Wu S.Y., Hennis A., et al. Incidence of diabetic retinopathy in the Barbados Eye Studies. Ophthalmology 2003, 110:941-947.
146. Leske M.C., Wu S.Y., Hennis A., et al. Nine-year incidence of diabetic retinopathy in the Barbados Eye Studies. Arch Ophthalmol 2006, 124:250-255.
147. Leske M.C., Wu S.Y., Hyman L., et al. Diabetic retinopathy in a black population: the Barbados Eye Study. Ophthalmology 1999, 106:1893-1899.
148. Lim A., Stewart J., Chui T.Y., et al. Prevalence and risk factors of diabetic retinopathy in a multi-racial underserved population. Ophthalmic Epidemiol 2008, 15:402-409.
149. Lim S., Chellumuthi C., Crook N., et al. Low prevalence of retinopathy, but high prevalence of nephropathy among Maori with newly diagnosed diabetes-Te Wai o Rona: Diabetes Prevention Strategy. Diabetes Res Clin Pract 2008, 80:271-274.
150. Lind M., Oden A., Fahlen M., et al. The shape of the metabolic memory of HbA1c: re-analysing the DCCT with respect to time-dependent effects. Diabetologia 2010, 53:1093-1098.
151. Ling R., Ramsewak V., Taylor D., et al. Longitudinal study of a cohort of people with diabetes screened by the Exeter Diabetic Retinopathy Screening Programme. Eye (Lond) 2002, 16:140-145.
152. Liu D.P., Molyneaux L., Chua E., et al. Retinopathy in a Chinese population with type 2 diabetes: factors affecting the presence of this complication at diagnosis of diabetes. Diabetes Res Clin Pract 2002, 56:125-131.
153. Looker H.C., Nelson R.G., Chew E., et al. Genome-wide linkage analyses to identify Loci for diabetic retinopathy. Diabetes 2007, 56:1160-1166.
154. Maberley D.A., King W., Cruess A.F., et al. Risk factors for diabetic retinopathy in the Cree of James Bay. Ophthalmic Epidemiol 2002, 9:153-167.
155. Maguire A., Chan A., Cusumano J., et al. The case for biennial retinopathy screening in children and adolescents. Diabetes Care 2005, 28:509-513.
156. Mahal S., Strain W.D., Martinez-Perez M.E., et al. Comparison of the retinal microvasculature in European and African Caribbean people with diabetes. Clin Sci (Lond) 2009, 117:229-236.
157. Majaliwa E.S., Munubhi E., Ramaiya K., et al. Survey on acute and chronic complications in children and adolescents with type 1 diabetes at Muhimbili National Hospital in Dar es Salaam, Tanzania. Diabetes Care 2007, 30:2187-2192.
158. Manaviat M.R., Afkhami M., Shoja M.R. Retinopathy and microalbuminuria in type II diabetic patients. BMC Ophthalmol 2004, 4:9.
159. Manaviat M.R., Rashidi M., Afkhami-Ardekani M., et al. Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients. BMC Ophthalmol 2008, 8:10.
160. Maple-Brown L., Cunningham J., Dunne K., et al. Complications of diabetes in urban Indigenous Australians: the DRUID study. Diabetes Res Clin Pract 2008, 80:455-462.
161. Massin P., Erginay A., Mercat-Caudal I., et al. Prevalence of diabetic retinopathy in children and adolescents with type 1 diabetes attending summer camps in France. Diabetes Metab 2007, 33:284-289.
162. Mayer-Davis E.J., Bell R.A., Dabelea D., et al. The many faces of diabetes in American youth: type 1 and type 2 diabetes in five race and ethnic populations: the SEARCH for Diabetes in Youth Study. Diabetes Care 2009, 32(Suppl 2):S99-S101.
163. McCance D.R., Hadden D.R., Atkinson A.B., et al. Long-term glycaemic control and diabetic retinopathy. Lancet 1989, 2:824-828.
164. McCarty C.A., Taylor K.I., McKay R., et al. Diabetic retinopathy: effects of national guidelines on the referral, examination and treatment practices of ophthalmologists and optometrists. Clin Exp Ophthalmol 2001, 29:52-58.
165. Mendes A.B., Fittipaldi J.A., Neves R.C., et al. Prevalence and correlates of inadequate glycaemic control: results from a nationwide survey in 6,671 adults with diabetes in Brazil. Acta Diabetol 2010, 47:137-145.
166. Miljanovic B., Glynn R.J., Nathan D.M., et al. A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes 2004, 53:2883-2892.
167. Mitchell P. Development and progression of diabetic eye disease in Newcastle (1977-1984): rates and risk factors. Aust NZ J Ophthalmol 1985, 13:39-44.
168. Mitchell P., Smith W., Wang J.J., et al. Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study. Ophthalmology 1998, 105:406-411.
169. Mohan V., Meera R., Premalatha G., et al. Frequency of proteinuria in type 2 diabetes mellitus seen at a diabetes centre in southern India. Postgrad Med J 2000, 76:569-573.
170. Mohsin F., Craig M.E., Cusumano J., et al. Discordant trends in microvascular complications in adolescents with type 1 diabetes from 1990 to 2002. Diabetes Care 2005, 28:1974-1980.
171. Moore M.P., Lunt H. Diabetes in New Zealand. Diabetes Res Clin Pract 2000, 50(Suppl 2):S65-S71.
172. Morales A. A better future for children with type 1 diabetes: review of the conclusions from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study. J Ark Med Soc 2009, 106:90-93.
173. Moreira E.D., Neves R.C., Nunes Z.O., et al. Glycemic control and its correlates in patients with diabetes in Venezuela: results from a nationwide survey. Diabetes Res Clin Pract 2010, 87:407-414.
174. Morisaki N., Watanabe S., Kobayashi J., et al. Diabetic control and progression of retinopathy in elderly patients: five-year follow-up study. J Am Geriatr Soc 1994, 42:142-145.
175. Motala A.A., Pirie F.J., Gouws E., et al. Microvascular complications in South African patients with long-duration diabetes mellitus. S Afr Med J 2001, 91:987-992.
176. Moussa M.A., Alsaeid M., Abdella N., et al. Prevalence of type 1 diabetes among 6- to 18-year-old Kuwaiti children. Med Princ Pract 2005, 14:87-91.
177. Muller A., Keeffe J.E., Taylor H.R. Changes in eye care utilization following an eye health promotion campaign. Clin Experiment Ophthalmol 2007, 35:305-309.
178. Munoz B., West S.K., Rubin G.S., et al. Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol 2000, 118:819-825.
179. Nagi D.K., Pettitt D.J., Bennett P.H., et al. Diabetic retinopathy assessed by fundus photography in Pima Indians with impaired glucose tolerance and NIDDM. Diabet Med 1997, 14:449-456.
180. Namperumalsamy P., Kim R., Vignesh T.P., et al. Prevalence and risk factors for diabetic retinopathy: a population-based assessment from Theni District, south India. Br J Ophthalmol 2009, 93:429-434.
181. Naqshbandi M., Harris S.B., Esler J.G., Antwi-Nsiah F. Global complication rates of type 2 diabetes in Indigenous peoples: a comprehensive review. Diabetes Res Clin Pract 2008, 82:1-17.
182. Narendran V., John R.K., Raghuram A., et al. Diabetic retinopathy among self reported diabetics in southern India: a population based assessment. Br J Ophthalmol 2002, 86:1014-1018.
183. Nayak S.B., Bhaktha G. Relationship between sialic acid and metabolic variables in Indian type 2 diabetic patients. Lipids Health Dis 2005, 4:15.
184. Nguyen T.T., Wang J.J., Sharrett A.R., et al. Relationship of retinal vascular caliber with diabetes and retinopathy: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 2008, 31:544-549.
185. Nitiyanant W., Tandhanand S., Mahtab H., et al. The Diabcare-Asia 1998 study--outcomes on control and complications in type 1 and type 2 diabetic patients. Curr Med Res Opin 2002, 18:317-327.
186. Nordwall M., Hyllienmark L., Ludvigsson J. Early diabetic complications in a population of young patients with type 1 diabetes mellitus despite intensive treatment. J Pediatr Endocrinol Metab 2006, 19:45-54.
187. Ogawa Y., Uchigata Y., Iwamoto Y. Progression factors of carotid intima-media thickness and plaque in patients with long-term, early-onset type 1 diabetes mellitus in Japan: simultaneous comparison with diabetic retinopathy. J Atheroscler Thromb 2009, 16:821-828.
188. Olivarius N.F., Beck-Nielsen H., Andreasen A.H., et al. Randomised controlled trial of structured personal care of type 2 diabetes mellitus. BMJ 2001, 323:970-975.
189. Olsen B.S., Johannesen J., Sjolie A.K., et al. Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood. Diabet Med 1999, 16:79-85.
190. Orr P., Barron Y., Schein O.D., et al. Eye care utilization by older Americans: the SEE Project. Salisbury Eye Evaluation. Ophthalmology 1999, 106:904-909.
191. Oster R.T., Toth E.L. Differences in the prevalence of diabetes risk-factors among First Nation, Metis and non-Aboriginal adults attending screening clinics in rural Alberta, Canada. Rural Remote Health 2009, 9:1170.
192. Oster R.T., Virani S., Strong D., et al. Diabetes care and health status of First Nations individuals with type 2 diabetes in Alberta. Can Fam Physician 2009, 55:386-393.
193. Pambianco G., Costacou T., Orchard T.J. The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes Care 2007, 30:1248-1254.
194. Paudyal G., Shrestha M.K., Meyer J.J., et al. Prevalence of diabetic retinopathy following a community screening for diabetes. Nepal Med Coll J 2008, 10:160-163.
195. Pedro R.A., Ramon S.A., Marc B.B., et al. Prevalence and relationship between diabetic retinopathy and nephropathy, and its risk factors in the North-East of Spain, a population-based study. Ophthalmic Epidemiol 2010, 17:251-265.
196. Perez-Escamilla R., Putnik P. The role of acculturation in nutrition, lifestyle, and incidence of type 2 diabetes among Latinos. J Nutr 2007, 137:860-870.
197. Pinto-Figueiredo L., Moita J., Genro V., et al. Diabetic retinopathy in a population of 1,302 insulin dependent diabetics (IDDM) diagnosed before 30 years of age. Int Ophthalmol 1992, 16:429-437.
198. Povlsen L., Olsen B., Ladelund S. Diabetes in children and adolescents from ethnic minorities: barriers to education, treatment and good metabolic control. J Adv Nurs 2005, 50:576-582.
199. Povlsen L., Olsen B., Ladelund S. Educating families from ethnic minorities in type 1 diabetes-experiences from a Danish intervention study. Patient Educ Couns 2005, 59:164-170.
200. Pradeepa R., Anitha B., Mohan V., et al. Risk factors for diabetic retinopathy in a South Indian Type 2 diabetic population-the Chennai Urban Rural Epidemiology Study (CURES) Eye Study 4. Diabet Med 2008, 25:536-542.
201. Premanand C., Rema M., Sameer M.Z., et al. Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions. Invest Ophthalmol Vis Sci 2006, 47:2179-2184.
202. Radha V., Rema M., Mohan V. Genes and diabetic retinopathy. Indian J Ophthalmol 2002, 50:5-11.
203. Rajala U., Laakso M., Qiao Q., et al. Prevalence of retinopathy in people with diabetes, impaired glucose tolerance, and normal glucose tolerance. Diabetes Care 1998, 21:1664-1669.
204. Ramachandran A., Snehalatha C., Sasikala R., et al. Vascular complications in young Asian Indian patients with type 1 diabetes mellitus. Diabetes Res Clin Pract 2000, 48:51-56.
205. Ramachandran A., Snehalatha C., Satyavani K., et al. Prevalence of vascular complications and their risk factors in type 2 diabetes. J Assoc Physicians India 1999, 47:1152-1156.
206. Ramachandran A., Snehalatha C., Vijay V., et al. Impact of poverty on the prevalence of diabetes and its complications in urban southern India. Diabet Med 2002, 19:130-135.
207. Raman R., Rani P.K., Gnanamoorthy P., et al. Association of obesity with diabetic retinopathy: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS Report no. 8). Acta Diabetol 2010, 47:209-215.
208. Raman R., Rani P.K., Kulothungan V., et al. Influence of serum lipids on clinically significant versus nonclinically significant macular edema: SN-DREAMS Report number 13. Ophthalmology 2010, 117:766-772.
209. Raman R., Rani P.K., Reddi R.S., et al. Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2. Ophthalmology 2009, 116:311-318.
210. Raman R., Vaitheeswaran K., Vinita K., et al. Is prevalence of retinopathy related to the age of onset of diabetes? Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Report No. 5. Ophthalmic Res 2011, 45:36-41.
211. Rani P.K., Raman R., Chandrakantan A., et al. Risk factors for diabetic retinopathy in self-reported rural population with diabetes. J Postgrad Med 2009, 55:92-96.
212. Rani P.K., Raman R., Sharma V., et al. Analysis of a comprehensive diabetic retinopathy screening model for rural and urban diabetics in developing countries. Br J Ophthalmol 2007, 91:1425-1429.
213. Ranil P.K., Raman R., Rachepalli S.R., et al. Anemia and diabetic retinopathy in type 2 diabetes mellitus. J Assoc Physicians India 2010, 58:91-94.
214. Raymond N.T., Varadhan L., Reynold D.R., et al. Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: a cross-sectional study. Diabetes Care 2009, 32:410-415.
215. Rema M., Deepa R., Mohan V. Prevalence of retinopathy at diagnosis among type 2 diabetic patients attending a diabetic centre in South India. Br J Ophthalmol 2000, 84:1058-1060.
216. Rema M., Mohan V. Retinopathy at diagnosis among young Asian diabetic patients: the ASDIAB Study Group. Diabetes 2002, 51(Suppl 2):A206-A207.
217. Rema M., Ponnaiya M., Mohan V. Prevalence of retinopathy in non insulin dependent diabetes mellitus at a diabetes centre in southern India. Diabetes Res Clin Pract 1996, 34:29-36.
218. Rema M., Premkumar S., Anitha B., et al. Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. Invest Ophthalmol Vis Sci 2005, 46:2328-2333.
219. Rema M., Saravanan G., Deepa R., et al. Familial clustering of diabetic retinopathy in South Indian Type 2 diabetic patients. Diabet Med 2002, 19:910-916.
220. Rema M., Srivastava B.K., Anitha B., et al. Association of serum lipids with diabetic retinopathy in urban South Indians-the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-2. Diabet Med 2006, 23:1029-1036.
221. Riste L., Khan F., Cruickshank K. High prevalence of type 2 diabetes in all ethnic groups, including Europeans, in a British inner city: relative poverty, history, inactivity, or 21st century Europe?. Diabetes Care 2001, 24:1377-1383.
222. Rodrigues T.C., Canani L.H., Viatroski R.S., et al. Masked hypertension, nocturnal blood pressure and retinopathy in normotensive patients with type 1 diabetes. Diabetes Res Clin Pract 2010, 87:240-245.
223. Rogers S.L., Tikellis G., Cheung N., et al. Retinal arteriolar caliber predicts incident retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Diabetes Care 2008, 31:761-763.
224. Ross S.A., McKenna A., Mozejko S., et al. Diabetic retinopathy in native and nonnative Canadians. Exp Diabetes Res 2007, 2007:1-6.
225. Rotimi C., Daniel H., Zhou J., et al. Prevalence and determinants of diabetic retinopathy and cataracts in West African type 2 diabetes patients. Ethn Dis 2003, 13:S110-S117.
226. Roy M.S. Diabetic retinopathy in African Americans with type 1 diabetes: The New Jersey 725: I. Methodology, population, frequency of retinopathy, and visual impairment. Arch Ophthalmol 2000, 118:97-104.
227. Roy M.S., Janal M.N. High caloric and sodium intakes as risk factors for progression of retinopathy in type 1 diabetes mellitus. Arch Ophthalmol 2010, 128:33-39.
228. Saadi H., Carruthers S.G., Nagelkerke N., et al. Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates. Diabetes Res Clin Pract 2007, 78:369-377.
229. Salti H.I., Nasrallah M.P., Taleb N.M., et al. Prevalence and determinants of retinopathy in a cohort of Lebanese type II diabetic patients. Can J Ophthalmol 2009, 44:308-313.
230. Sano H., Nishimura R., Asao K., et al. Blindness and laser photocoagulation in patients with childhood-onset type 1 diabetes in Japan. Br J Ophthalmol 2009, 93:726-730.
231. Scanlon P.H. The English national screening programme for sight-threatening diabetic retinopathy. J Med Screen 2008, 15:1-4.
232. Schrier R.W., Estacio R.O., Mehler P.S., et al. Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial. Nat Clin Pract Nephrol 2007, 3:428-438.
233. Schulz L.O., Lalicata M., Carnes D., et al. Prevalence of diabetes and factors associated with diabetic complications in Oneida Indians. Life Sci 1997, 60:299-306.
234. Scott A., Whitcombe S., Bouchier D., et al. Diabetes in children and young adults in Waikato Province, New Zealand: outcomes of care. NZ Med J 2004, 117:U1219.
235. Sehnaz Karadeniz Z., Temel Y.M. Duration of diabetes and prevalence of diabetic retinopathy: Istanbul Diabetic Retinopathy Study-IDRS results 1 retinopathy. Diabetes Metab Syndr 2007, 1:43-48.
236. Sharp C.L., Butterfield W.J., Keen H. Diabetes survey in Bedford. Proc R Soc Med 1964, 57:193-202.
237. Shera A.S., Jawad F., Maqsood A. Prevalence of diabetes in Pakistan. Diabetes Res Clin Pract 2007, 76:219-222.
238. Simmons D., Williams D.R., Powell M.J. Prevalence of diabetes in a predominantly Asian community: preliminary findings of the Coventry diabetes study. BMJ 1989, 298:18-21.
239. Simmons D., Williams D.R., Powell M.J. The Coventry Diabetes Study: prevalence of diabetes and impaired glucose tolerance in Europids and Asians. Q J Med 1991, 81:1021-1030.
240. Sjolie A.K. Ocular complications in insulin treated diabetes mellitus. An epidemiological study. Acta Ophthalmol 1985, 172(Suppl):1-77.
241. Sloan F.A., Belsky D., Ruiz D., et al. Changes in incidence of diabetes mellitus-related eye disease among US elderly persons, 1994-2005. Arch Ophthalmol 2008, 126:1548-1553.
242. Sloan F.A., Brown D.S., Carlisle E.S., et al. Monitoring visual status: why patients do or do not comply with practice guidelines. Health Serv Res 2004, 39:1429-1448.
243. Smith T.S., Szetu J., Bourne R.R. The prevalence and severity of diabetic retinopathy, associated risk factors and vision loss in patients registered with type 2 diabetes in Luganville, Vanuatu. Br J Ophthalmol 2007, 91:415-419.
244. Soljak M.A., Majeed A., Eliahoo J., et al. Ethnic inequalities in the treatment and outcome of diabetes in three English Primary Care Trusts. Int J Equity Health 2007, 6:8.
245. Sparrow J.M., McLeod B.K., Smith T.D., et al. The prevalence of diabetic retinopathy and maculopathy and their risk factors in the non-insulin-treated diabetic patients of an English town. Eye 1993, 7(Pt 1):158-163.
246. Spijkerman A.M., Dekker J.M., Nijpels G., et al. Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the hoorn screening study. Diabetes Care 2003, 26:2604-2608.
247. Stephenson J.M., Fuller J.H., Viberti G.C., et al. Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study. Diabetologia 1995, 38:599-603.
248. Stolk R.P., van Schooneveld M.J., Cruickshank J.K., et al. Retinal vascular lesions in patients of Caucasian and Asian origin with type 2 diabetes: baseline results from the ADVANCE Retinal Measurements (AdRem) study. Diabetes Care 2008, 31:708-713.
249. Stolk R.P., Vingerling J.R., de Jong P.T., et al. Retinopathy, glucose, and insulin in an elderly population. The Rotterdam Study. Diabetes 1995, 44:11-15.
250. Strain W.D., Chaturvedi N., Leggetter S., et al. Ethnic differences in skin microvascular function and their relation to cardiac target-organ damage. J Hypertens 2005, 23:133-140.
251. Svensson J., Johannesen J., Mortensen H.B., et al. Improved metabolic outcome in a Danish diabetic paediatric population aged 0-18 yr: results from a nationwide continuous Registration. Pediatr Diabetes 2009, 10:461-467.
252. Takeuchi M., Okamoto K., Takagi T., et al. Ethnic difference in inter-East Asian subjects with normal glucose tolerance and impaired glucose regulation: a systematic review and meta-analysis focusing on fasting serum insulin. Diabetes Res Clin Pract 2008, 82:383-390.
253. Tam T.K., Lau C.M., Tsang L.C., et al. Epidemiological study of diabetic retinopathy in a primary care setting in Hong Kong. Hong Kong Med J 2005, 11:438-444.
254. Tam V.H., Lam E.P., Chu B.C., et al. Incidence and progression of diabetic retinopathy in Hong Kong Chinese with type 2 diabetes mellitus. J Diabetes Complicat 2009, 23:185-193.
255. Tapp R.J., Shaw J.E., Harper C.A., et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 2003, 26:1731-1737.
256. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986. The Diabetes Control and Complications Trial Research Group.
257. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. Diabetes Care 2000, 23:1084-1091. The Diabetes Control and Complications Trial Research Group.
258. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002, 287:2563-2569. The Diabetes Control and Complications Trial Research Group.
259. Tudor S.M., Hamman R.F., Baron A., et al. Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes. San Luis Valley Diabetes Study, Colorado. Diabetes Care 1998, 21:53-61.
260. UK Prospective Diabetes Study. XII: Differences between Asian, Afro-Caribbean and white Caucasian type 2 diabetic patients at diagnosis of diabetes. Diabet Med 1994, 11:670-677. UK Prospective Diabetes Study (UKPDS) Group.
261. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. UK Prospective Diabetes Study (UKPDS) Group.
262. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998, 317:703-713. UK Prospective Diabetes Study (UKPDS) Group.
263. Uthra S., Raman R., Mukesh B.N., et al. Diabetic retinopathy: Validation study of ALR2, RAGE, iNOS and TNFB gene variants in a south Indian cohort. Ophthalmic Genet 2010, 31:244-251.
264. van D.S., Beulens J.W., van der Schouw Y.T., et al. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil 2010, 17(Suppl 1):S3-S8.
265. Varma R., Choudhury F., Klein R., et al. Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study. Am J Ophthalmol 2010, 149:752-761.
266. Varma R., Chung J., Foong A.W., et al. Four-year incidence and progression of visual impairment in Latinos: the Los Angeles Latino Eye Study. Am J Ophthalmol 2010, 149:713-727.
267. Varma R., Torres M., Pena F., et al. Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. Ophthalmology 2004, 111:1298-1306.
268. Wahab S., Mahmood N., Shaikh Z., et al. Frequency of retinopathy in newly diagnosed type 2 diabetes patients. J Pak Med Assoc 2008, 58:557-561.
269. Walsh M.G., Zgibor J., Borch-Johnsen K., et al. A multinational assessment of complications in type 1 diabetes: the DiaMond substudy of complications (DiaComp) level 1. Diab Vasc Dis Res 2006, 3:84-92.
270. Wang F.H., Liang Y.B., Zhang F., et al. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology 2009, 116:461-467.
271. Wang W.Q., Ip T.P., Lam K.S. Changing prevalence of retinopathy in newly diagnosed non-insulin dependent diabetes mellitus patients in Hong Kong. Diabetes Res Clin Pract 1998, 39:185-191.
272. Weerasuriya N., Siribaddana S., Dissanayake A., et al. Long-term complications in newly diagnosed Sri Lankan patients with type 2 diabetes mellitus. QJM 1998, 91:439-443.
273. West K.M., Ahuja M.M., Bennett P.H., et al. Interrelationships of microangiopathy, plasma glucose and other risk factors in 3583 diabetic patients: a multinational study. Diabetologia 1982, 22:412-420.
274. West S.K., Klein R., Rodriguez J., et al. Diabetes and diabetic retinopathy in a Mexican American population: Proyecto VER. Diabetes Care 2001, 24:1204-1209.
275. White N.H., Sun W., Cleary P.A., et al. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes 2010, 59:1244-1253.
276. WHO launches Vision 2020 to combat avoidable blindness. Public Health Rep 1999, 114:210. World Health Organisation.
277. Wild S., Roglic G., Green A., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
278. Williams R., Airey M., Baxter H., et al. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye (Lond) 2004, 18:963-983.
279. Wilson M.R., Eezzuduemhoi D.R. Ophthalmologic disorders in minority populations. Med Clin North Am 2005, 89:795-804.
280. Wong K.C., Wang Z. Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Res Clin Pract 2006, 73:126-134.
281. Wong T.Y., Cheung N., Tay W.T., et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology 2008, 115:1869-1875.
282. Wong T.Y., Klein R., Islam F.M., et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol 2006, 141:446-455.
283. Wulan S.N., Westerterp K.R., Plasqui G. Ethnic differences in body composition and the associated metabolic profile: a comparative study between Asians and Caucasians. Maturitas 2010, 65:315-319.
284. Xie X.W., Xu L., Jonas J.B., et al. Prevalence of diabetic retinopathy among subjects with known diabetes in China: the Beijing Eye Study. Eur J Ophthalmol 2009, 19:91-99.
285. Yang J.K., Liu W., Shi J., et al. An association between subclinical hypothyroidism and sight-threatening diabetic retinopathy in type 2 diabetic patients. Diabetes Care 2010, 33:1018-1020.
286. Younis N., Broadbent D.M., Vora J.P., et al. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 2003, 361:195-200.
287. Zhang H., Xia W., Yu Q., et al. Increasing incidence of type 1 diabetes in children aged 0-14 years in Harbin, China (1990-2000). Prim Care Diabetes 2008, 2:121-126.
288. Zhang X., Gregg E.W., Cheng Y.J., et al. Diabetes mellitus and visual impairment: national health and nutrition examination survey, 1999-2004. Arch Ophthalmol 2008, 126:1421-1427.
289. Zhang X., Saaddine J.B., Chou C.F., et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 2010, 304:649-656.
290. Zimmet P., King H., Taylor R., et al. The high prevalence of diabetes mellitus, impaired glucose tolerance and diabetic retinopathy in Nauru-the 1982 survey. Diabetes Res 1984, 1:13-18.